Palvella Therapeutics (PVLA) Current Leases (2021 - 2026)

Palvella Therapeutics (PVLA) has 5 years of Current Leases data on file, last reported at $209000.0 in Q1 2026.

• Current Leases for Q1 2026 came in at $209000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $209000.0 (changed N/A YoY), and the FY2025 annual result was $202000.0, changed N/A from the prior year.
• Current Leases rose to $209000.0 in Q1 2026 per PVLA's latest filing, from $202000.0 in the prior quarter.
• Over five years, Current Leases peaked at $12.3 million in Q3 2023 and troughed at $202000.0 in Q4 2025.
• A 4-year average of $2.3 million and a median of $859000.0 in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2023: Current Leases declined 18.11% in 2022, then surged 1388.14% in 2023.
• A 4-year view of Current Leases shows it stood at $859000.0 in 2022, then surged by 1330.97% to $12.3 million in 2023, then sank by 98.36% to $202000.0 in 2025, then advanced by 3.47% to $209000.0 in 2026.
• Business Quant data shows PVLA's Current Leases at $209000.0 in Q1 2026, $202000.0 in Q4 2025, and $12.3 million in Q3 2023.